Bio Impact Capital LLC Cytokinetics Inc Transaction History

Bio Impact Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$38.54 - $54.52 $40,120 - $56,755	-1,041 Reduced 0.54%	193,205 $9.36 Million
Q2 2022 Aug 11, 2022	SELL	$33.93 - $48.92 $1.02 Million - $1.47 Million	-30,000 Reduced 13.38%	194,246 $7.63 Million
Q1 2022 May 13, 2022	SELL	$29.74 - $46.0 $238,574 - $369,012	-8,022 Reduced 3.45%	224,246 $8.25 Million
Q4 2021 Feb 11, 2022	SELL	$34.35 - $46.38 $516,040 - $696,766	-15,023 Reduced 6.08%	232,268 $10.6 Million
Q3 2021 Nov 15, 2021	BUY	$18.54 - $35.74 $4.58 Million - $8.84 Million	247,291 New	247,291 $8.84 Million

409

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.6B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Bio Impact Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Bio Impact Capital LLC with notifications on news.